oxidopamine has been researched along with Invasiveness, Neoplasm in 2 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hodgson, DM | 1 |
| Yirmiya, R | 1 |
| Chiappelli, F | 1 |
| Taylor, AN | 1 |
| Yanagawa, Y | 1 |
2 other studies available for oxidopamine and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Intracerebral interleukin-1beta impairs response to tumor invasion: involvement of adrenal catecholamines.
Topics: Adrenal Glands; Adrenalectomy; Adrenergic Antagonists; Animals; Catecholamines; Corticosterone; Hypo | 1999 |
[The relationship of the occurrence and growth of experimental cervical carcinoma to the local sympathetic nervous system].
Topics: Animals; Cervix Uteri; Female; Hydroxydopamines; Methylcholanthrene; Mice; Neoplasm Invasiveness; No | 1988 |